M3
M3, Inc. (TSE Prime: 2413) operates m3.com, the world's largest physician platform with 350,000+ Japanese doctors and 6.5M+ globally, selling pharma marketing, clinical trial services, cloud EHR, AI diagnostics, and corporate wellness to pharmaceutical, healthcare provider, clinic, and employer customers across 15+ countries.
- Company typePublic
- Founded2002
- HeadquartersTokyo, Japan
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingSoftware
What M3 does
M3, Inc. (TSE Prime: 2413) operates the world's largest physician membership platform, anchored by m3.com in Japan with 350,000+ registered doctors covering over 90% of Japanese physicians, and an international footprint (Doctors.net.uk in the UK, MEDI:GATE in Korea covering 70%+ of Korean doctors, MDLinx in the US, VIDAL across France/Germany/Spain, plus subsidiaries in China, India, Australia and Russia). The company sits on a consolidated headcount of 17,010 employees as of March 2026, is a Nikkei 225 constituent (the first post-2000 venture company included), and has grown from its 2000 founding into a publicly listed Prime Market operator with ¥294.32B registered capital.
M3's product portfolio spans a platform-plus-modules architecture. The core platform is m3.com, complemented by MR-kun (pharma e-detailing with 92% physician-reported deepened disease awareness), QOL-kun, Web seminars drawing 1,000+ attendees per session, clinical trial recruitment (Chiken-kun, leveraging 80%+ of Japanese doctors for trial feasibility), M3 DigiKar (Japan's #1 cloud EHR by market share for three consecutive years, managing 36M+ patient records across 3,000+ clinics), and the M3 AI Platform aggregating global diagnostic image AI solutions. Adjacent services include physician and pharmacist recruitment (m3.com CAREER, 薬キャリ), consumer health Q&A (AskDoctors, QLife with 30M+ monthly users), corporate wellness (White Jack Project, EBHS Life, GO100), and patient support via ELAN. M3 DigiKar integrates with Stripe for cashless payments, and M3 partnered with LINE Healthcare for online consultations.
M3's revenue model is primarily subscription and enterprise-contract based. Pharmaceutical marketing and promotion services (MR-kun, QOL-kun, Web seminars) anchor revenues, charged as recurring subscriptions and service fees for access to the physician network and marketing execution. Clinical trial and CRO services (Chiken-kun, Mediscience Planning) generate per-protocol and project fees. Cloud EHR and clinic SaaS (M3 DigiKar, Digisuma) run on SaaS subscriptions. Physician and pharmacist recruitment, healthcare research panels (including the acquired Kantar health panels), consumer health platforms, and corporate health management (White Jack, M3PSP, occupational physician placement) round out a diversified, multi-segment revenue mix. M3 pursues expansion primarily through M&A — 20+ acquisitions across the 2022–2026 period — and uses a ¥10B corporate venture fund (1 Person 1 Yen) for ecosystem investing, alongside active capital return via share buybacks.
M3 firmographics
Firmographics- Name
- M3
- Legal name
- エムスリー株式会社
- Website
- https://corporate.m3.com/
- Company type
- Public
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- M3, Inc. (TSE Prime: 2413) operates m3.com, the world's largest physician platform with 350,000+ Japanese doctors and 6.5M+ globally, selling pharma marketing, clinical trial services, cloud EHR, AI diagnostics, and corporate wellness to pharmaceutical, healthcare provider, clinic, and employer customers across 15+ countries.
- Ownership category
- akta.pro rank
M3 industry classification
Industry- Product category
- Healthcare Technology Platform
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Healthcare On‑Demand Platforms (Telehealth, Home Care, Nursing) (BPAMAHAH)
- akta.pro secondary industry
- Ambulatory & Physician Practice EHRs (HLACAAAB)
Keywords
Where M3 is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
M3 business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Pharmaceutical Marketing & Promotion Services: Subscription and service fees from pharmaceutical companies for MR君 (e-detailing), QOL君, Web seminars, and other marketing/promotion tools delivered to physicians via m3.com. Pharma companies pay for access to M3's physician network and marketing execution services.
- Physician & Pharmacist Recruitment: Job placement and recruitment services for physicians (m3.com CAREER) and pharmacists (薬キャリ), including job advertisements and placement fees.
- Clinical Trial Services: 治験君 service for clinical trial site and patient recruitment, and CRO services through Mediscience Planning, generating fees per protocol and project.
- Healthcare Research Panels: Survey and research panel services for pharmaceutical companies, consulting firms, and other clients, leveraging M3's physician and consumer panels in Japan and globally.
- Cloud EHR & Clinic SaaS: Subscription fees from M3 DigiKar (cloud EHR) and デジスマ診療 (clinic management/payment SaaS) sold to clinics and hospitals.
- Consumer Health Services: Consumer-facing services including AskDoctors (Q&A with physicians) and AskDoctors総研 (physician-backed product evaluation/marketing), plus patient engagement and support programs for enterprises.
- Corporate Health Management: Enterprise health management solutions including EBHS Life assessments, occupational physician placement (4,500+ installations), and the White Jack Project preventive healthcare program.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Web conferencing service starting package |
| Usage-based | Pay-as-you-go | m3 Fast Survey quick research service |
| Subscription | Monthly | AskDoctors smartphone subscription |
Go-to-market motion4 records
Distribution channels8 records
Marketing channels8 records
M3 product offering
Product offeringCore offering
M3 operates the m3.com physician portal platform serving more than 350,000 Japanese physicians (over 90% of Japan's doctors), enabling pharmaceutical companies to deliver targeted e-detailing, digital marketing, web-based seminars, and clinical trial recruitment services. The company also provides cloud-based electronic health records (M3 DigiKar), diagnostic AI platforms, patient support programs, physician and pharmacist recruitment services, and consumer-facing health services such as AskDoctors, with revenue primarily generated through subscription-based marketing services and SaaS subscriptions from pharmaceutical companies and clinics.
Product overview
M3 operates a platform-plus-modules architecture centered on m3.com, Japan's dominant physician portal with 350,000+ doctors (over 90% of Japanese physicians). The core platform integrates content (MR君 e-detailing, Web演唱会 web seminars, clinical news), career services (m3.com CAREER physician recruitment, 薬キャリ pharmacist recruitment), clinical trial support (治驗君), and consumer health (AskDoctors). M3 DigiKar provides cloud-based EMR ranked #1 in market share. The M3 AI Platform aggregates diagnostic image AI from global vendors. M3 PSP delivers corporate employee health support. White Jack Project and GO100 address preventive medicine. Subsidiaries include QLife (consumer healthcare media), iTicket Cloud (appointment scheduling), and international platforms MDLinx (US) and MEDI:GATE (Korea). The portfolio extends from HCP engagement to patient care, clinical trials, and health management across Japan and global markets.
Differentiator
Problem solved
Functional benefit
Brands
- m3.com: Japan's largest medical professional portal site with 350,000+ physician members providing news, clinical information, career services, and community features
- MR君
- Web招聘会
- AskDoctors
- m3.com CAREER
- 薬キャリ
- 治験君
- M3 DigiKar (デジカル)
- White Jack Project
- M3 AI Platform
- M3 PSP (Patient Support Program)
Quantifiable outcome
- 92% of physicians reported 'deepened disease awareness' and 94% were 'satisfied with content' from MR君 service
- +7 more outcomes
Companies that use M3
Customer profileNamed customers9 records
Segments7 records
Ideal customer profiles5 records
M3 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability8 records
Feature8 records
M3 partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- MinaCare (Minacare)coreM3 established MinaCare as a subsidiary offering support services for health insurance associations, part of broader M&A and business succession activities in internet-related healthcare services.
- Infrastructure for On Call Cooperation (当直連携基盤)coreThe on-call collaboration platform became a member of the M3 Group, leveraging its domestic physician membership base to expand services. Integration aims to improve service stability and quality, with Nakao continuing as representative director.
- MesslycoreAcquisition of Messly, a UK-based recruitment marketplace for locum doctors, to strengthen healthcare staffing solutions in the UK. Aims to address doctor shortages and expand medical staffing and workforce management services.
- Logic Inc.coreLogic Inc. became an M3 subsidiary as a SaaS provider of a care record system for nursing care facilities. Global Brain supported Logic through prior investments and strategic guidance.
- MirVracha LLCcoreAcquisition of MirVracha LLC in Russia to develop a physician platform business in Russia, marking M3's entry into the Russian healthcare market.
- HeartflowminorM3 was compared against Heartflow (NASDAQ: HTFL) in a financial analysis across nine metrics, with M3 outperforming on five of nine factors. Heartflow is a US-based AI medical technology company specializing in non-invasive coronary artery disease diagnosis.
Scale indicators8 records
Recent moves7 records
Expansion highlights8 records
M3 competitors and assessment
Company assessmentBroad incumbents
- Definitive Healthcare: Definitive Healthcare operates the leading commercial intelligence and analytics platform for the healthcare industry (provider, HCP, and pharma data) — broadly comparable to M3's physician panel, m3 Fast Survey, and Kantar-acquired research services at scale.
- Medscape (WebMD Professional): Medscape is the leading physician clinical content, news, and CME portal owned by WebMD — directly comparable to m3.com's content/news/CME functions and MDLinx's physician article digest service.
- Veeva Systems: Veeva is the dominant pharma commercial cloud (CRM, content, data) vendor globally — directly comparable to M3's MR君, QOL君, and pharma marketing SaaS franchises, though Veeva is broader (R&D/clinical/marketing) while M3 is more HCP-community-led.
- IQVIA: IQVIA is the global leader in clinical research services, real-world data, and healthcare commercial intelligence — overlapping with M3's 治験君 clinical trial recruitment, Mediscience Planning CRO, and physician panel research services, though IQVIA is far broader and more global.
Direct peers
- NextGen Healthcare: NextGen provides cloud-based ambulatory EHR, practice management, and patient engagement to specialty and primary care practices in the US — overlapping with M3 DigiKar and iTicket Cloud in ambulatory clinic SaaS.
- eClinicalWorks: eClinicalWorks is one of the largest US ambulatory EHR vendors serving physician practices — a direct product comparable to M3 DigiKar in cloud EHR and clinic management SaaS for outpatient providers.
- OPEN Health Group: OPEN Health is a global pharma communications and healthcare marketing services group offering medical affairs, marketing, and omnichannel engagement — directly comparable to M3's pharma marketing services (MR君, QOL君, Web講演会) at enterprise pharma customers.
- athenahealth: athenahealth is a leading US cloud-based ambulatory EHR and practice management SaaS — directly comparable to M3 DigiKar's #1-ranked cloud EHR business, serving similar small/mid-sized clinic customers with SaaS-led onboarding.
- Doximity: Doximity operates the largest verified-physician network in the US (~2M members) offering news, clinical references, telehealth, recruiting, and pharma marketing channels — the closest direct functional comparable to m3.com in Japan. Both monetize physician network effects through pharmaceutical promotion, recruiting, and adjacent SaaS.
- Sermo: Sermo is a verified-physician social community and market research panel used by pharma for HCP engagement — a direct functional analog to m3.com's physician-network and survey/research services, with similar community-led GTM.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
M3 social profiles
Digital presenceM3 financial estimates
Financial estimateRevenue estimate
Valuation estimate
M3 leadership team
Management profileNumber of profiles
Profiles12 records
M3 subsidiaries and ownership
Company hierarchySubsidiaries18 records
M3 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
M3 M&A and investment
M&A and investmentM&A12 records
Investments27 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about M3
What does M3 do?
M3 operates the m3.com physician portal platform serving more than 350,000 Japanese physicians (over 90% of Japan's doctors), enabling pharmaceutical companies to deliver targeted e-detailing, digital marketing, web-based seminars, and clinical trial recruitment services. The company also provides cloud-based electronic health records (M3 DigiKar), diagnostic AI platforms, patient support programs, physician and pharmacist recruitment services, and consumer-facing health services such as AskDoctors, with revenue primarily generated through subscription-based marketing services and SaaS subscriptions from pharmaceutical companies and clinics.
Is M3 a public or private company?
M3 is a public company. It is classified as public and is currently operating.
When was M3 founded?
M3 was founded in 2002. It employs 501 to 1,000 people.
Where is M3 based?
M3 is headquartered in Tokyo, Japan, in the Asia region.
How does M3 make money?
Seven revenue lines are on record. Pharmaceutical Marketing & Promotion Services are the primary driver. The others are physician & Pharmacist Recruitment, clinical Trial Services, healthcare Research Panels, cloud EHR & Clinic SaaS, consumer Health Services and corporate Health Management.
Who are M3's main competitors?
Broad incumbents on record are Definitive Healthcare, Medscape (WebMD Professional), Veeva Systems and IQVIA. Direct peers are NextGen Healthcare, eClinicalWorks, OPEN Health Group, athenahealth, Doximity and Sermo.
Does M3 have an API?
No public API is recorded for M3.
What industry is M3 in?
M3's product category is Healthcare Technology Platform. Its primary akta.pro industry code is BPAMAHAH, Healthcare On‑Demand Platforms (Telehealth, Home Care, Nursing), with a secondary code of HLACAAAB, Ambulatory & Physician Practice EHRs. Its NAICS code is 62111 and its SIC code is 8000.